Related Experiment Video

Updated: Jun 26, 2026

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN
11:50

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN

Published on: April 3, 2026

[Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer]

E A Anedchenko, A A Dmitriev, G S Krasnov

    Molekuliarnaia Biologiia
    |January 15, 2009
    PubMed

    Insights

    Chromosomal abnormalities in 3p are common in lung cancer. This study found frequent mRNA level decreases in six tumor-suppressor genes in non-small cell lung cancer (NSCLC), suggesting potential biomarkers for early diagnosis.

    Area of Science:

    • Genetics and Oncology
    • Molecular Biology

    Context:

    • Chromosomal abnormalities, specifically on chromosome 3p, are frequently observed in epithelial tumors, including lung cancer.
    • The 3p21.3 locus is known to harbor numerous cancer-related genes, with deletions often implicated in tumor development.

    Purpose:

    • To investigate the mRNA expression levels of six candidate tumor-suppressor genes (RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1, and HYAL2) located in the 3p21.3 region.
    • To analyze these expression levels in different histological subtypes of non-small cell lung cancer (NSCLC): squamous cell lung cancer (SCC) and lung adenocarcinoma (AC).
    • To correlate gene expression changes with clinicopathological features such as tumor stage, differentiation, and metastasis.

    Summary:

    • A significant and frequent decrease in mRNA levels (2-100 fold) was observed for all six genes in NSCLC, with variations between SCC and AC.
    • In AC, down-regulation of RASSF1A and ITGA9, and a similar trend for RBSP3/CTDSPL, NPRL2/G21, HYAL1, and HYAL2, correlated with tumor progression.
    • In SCC, significant mRNA down-regulation of RBSP3/CTDSPL, NPRL2/G21, ITGA9, HYAL1, and HYAL2 was observed early (stage I) and frequently (83-100%), without association with clinical stages or metastasis. Simultaneous down-regulation of all six genes was noted, suggesting co-regulation and potential coordinated inactivation. Genetic and epigenetic mechanisms were implicated in the down-regulation of RBSP3/CTDSPL and ITGA9.

    Impact:

    • The findings support the hypothesis of simultaneous inactivation of clustered cancer-related genes in the 3p21.3 locus during lung cancer development and progression.
    • The frequent and significant down-regulation of these six genes in early-stage SCC suggests their potential utility as biomarkers for early diagnosis.
    • These results may pave the way for developing novel therapeutic strategies targeting NSCLC.

    Related Concept Videos

    Negative Regulator Molecules01:23

    Negative Regulator Molecules

    Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
    The Ras Gene02:38

    The Ras Gene

    The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
    Ras is a superfamily...
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
    Small GTPases - Ras and Rho01:24

    Small GTPases - Ras and Rho

    Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
    Three regulatory proteins control their activity:
    The Retinoblastoma Gene01:20

    The Retinoblastoma Gene

    Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
    The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
    Receptor Downregulation in MVBs01:15

    Receptor Downregulation in MVBs

    Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
    The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...